Has Frederick Harada, MD received payments from drug or device companies?

Yes. Drug and device makers reported $6,145 in general payments to Frederick Harada, MD across 216 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Frederick Harada, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Frederick Harada, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Frederick Harada, MD

Dermatology · Honolulu, HINPI 1144313875

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 216 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 10.9% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,626, 3.8 times the $429 reported in 2019.

$6,145in general payments, 2019–2025

Across 216 payments — averaging $28.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

LEO Pharma Inc.$669
AbbVie$636
Sanofi$579
Sun Pharmaceutical Industries Inc.$533
Arcutis Biotherapeutics, Inc.$489
Incyte Corporation$481
plus $3K from 13 others

What the payments were for

Food & beverage$6,145100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
LEO Pharma Inc.	30	$669
AbbVie	25	$636
Sanofi	6	$579
Sun Pharmaceutical Industries Inc.	12	$533
Arcutis Biotherapeutics, Inc.	22	$489
Incyte Corporation	25	$481
Johnson & Johnson	17	$433
Lilly USA, LLC	14	$404
E.r. Squibb & Sons, L.L.C.	11	$285
Novartis	9	$278
UCB, Inc.	7	$261
Regeneron Healthcare Solutions, Inc.	7	$250
Galderma Laboratories, L.p.	6	$186
Pfizer	7	$180
Genentech USA, Inc.	8	$162
Dermavant Sciences, Inc.	2	$154
Organon	2	$61
Dermira, Inc.	2	$53
Amgen	4	$51

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,145 in reported general payments places this provider in the 65th percentile of 67 dermatology providers in Hawaii.

See all dermatology providers in Hawaii →

Medicare billing

Part B allowed, 2024

$237,465

Medicare patients

395

Services billed

6,957

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Tacrolimus	26	$7,064
Betamethasone Dipropionate	107	$4,359
Halobetasol Propionate	105	$4,170
Fluorouracil	27	$2,135
Ketoconazole	88	$1,841
Fluocinonide	27	$1,172
Ciclopirox	15	$879
Mometasone Furoate	29	$576
Clindamycin Phosphate	15	$407
Triamcinolone Acetonide	30	$320
CiclopiroxCiclopirox Olamine	16	$293
Mupirocin	35	$124
Hydrocortisone	11	$63
Prednisone	16	$59

Paid to pharmacies, not to this prescriber.

Other dermatology in Honolulu

Sarah HowellHonolulu$653K
Douglas JohnsonHonolulu$568K
Ryan SatoHonolulu$226K
Greg SakamotoHonolulu$20K
Kory KitagawaHonolulu$18K
Kevin DawsonHonolulu$16K
Dylan LeeHonolulu$15K
Sarah GrekinHonolulu$13K
Gregory HerbichHonolulu$12K
Stella MatsudaHonolulu$9K

See the full list for Hawaii →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →